AJP - Regu Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 291: R213-R223, 2006. First published February 2, 2006; doi:10.1152/ajpregu.00652.2005
0363-6119/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/1/R213    most recent
00652.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanna-Mitchell, A. T.
Right arrow Articles by Gebruers, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanna-Mitchell, A. T.
Right arrow Articles by Gebruers, E. M.

WATER AND ELECTROLYTE HOMEOSTASIS

The hydroosmotic response of frog urinary bladder to serosal hypertonicity is dependent on adenylate cyclase for its maintenance and affected by [Cl–]o changes

Ann T. Hanna-Mitchell and Elizabeth M. Gebruers

Department of Physiology, University College Cork, Cork, Ireland

Submitted 6 September 2005 ; accepted in final form 30 January 2006


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The role of adenylate cyclase (AC) in the maintenance of the hydroosmotic response to serosal hypertonicity (SH) in anuran urinary bladder is disputed. In this study, norepinephrine (NE) significantly reversed the hydroosmotic response of Rana temporaria bladders in hypertonic medium (330 mosmol/kgH2O). The reversal was inhibited by yohimbine but was unaffected by prazosin and propranolol, indicating that NE action was mediated via {alpha}2-adrenergic receptors. Preincubation of bladders with indomethacin did not interfere with the inhibitory action of NE, contraindicating a role for prostaglandins. The SH hydroosmotic response was abolished in the presence of 5-n-ethyl-N-isopropyl amiloride (EIPA), but the antidiuretic hormone (ADH) hydroosmotic response was not. EIPA inhibits Na+/H+, known to be activated by cell shrinkage. An investigation of the anionic requirement of the SH hydroosmotic response revealed that replacement of bath Cl– with the nonpermeable anion gluconate reversibly abolished this response. In contrast, the hydroosmotic response to ADH was unaffected by Cl– removal; however, when Cl– was absent, it was no longer augmented in hypertonic bath. The SH response was inhibited by the Cl– channel blocker 5-nitro-2-(3-phenylpropylamino)benzoate but not by the Na/K/2Cl inhibitor bumetanide. Our results show that not only the onset but also the maintenance of the SH hydroosmotic response is dependent on AC activity and does not differ in this respect to the ADH hydroosmotic response. The effect of modifying extracellular Cl– concentration, suggests that this anion, possibly functionally linked with Na+/H+ activity, may be involved in invoking the SH hydroosmotic response in anuran urinary bladder.

anuran; water balance; extracellular chloride

FROGS AND TOADS (anurans) are constantly under the threat of dehydration because of the high rate of evaporative water loss through their skin. With some exceptions (38), anurans do not hydrate orally; water balance is maintained by absorption of water (dermal drinking) through a specialized area of skin on the ventral surface, called the pelvic patch, and by reabsorption of fluid from the bladder (28). Transepithelial water movement in these tissues is through the granular cells, which are functionally analogous to the mammalian principal cell of the renal collecting duct. Although antidiuretic hormone (ADH) has been considered to regulate these events (9, 51), there are reports that anuran water balance can be maintained after ablation of the posterior pituitary (2, 55, 61).

ADH invokes a reversible increase in the permeability of the apical membranes of principal cells in the mammalian collecting duct and granular cells in anuran skin and bladder, allowing water movement across these tight epithelia. This hydroosmotic action of ADH is mediated via an increase in intracellular cAMP concentration (15, 22, 33). In the mammalian principal cell, ADH activation of V2 receptors causes a trafficking of vesicles, carrying the water channel protein aquaporin-2 to and from the apical membrane (39). In anuran granular cells, ADH causes a similar trafficking of vesicles (aggrephores) to and from the apical membrane (59), believed to carry water channels (7, 10, 37). The serosal hypertonicity (SH)-regulated water channel in anuran bladder remains to be cloned.

Bentley (4) described a reversible increase in water flux across toad bladder in response to hypertonic serosal bathing solutions that did not depend on the presence of ADH. Exposure of this tissue to SH results in the appearance of luminal membrane aggregates (14, 29) believed to be water channel proteins. SH responses in anuran bladder are related to a shrinkage effect (4), which led to the hypothesis that this hydroosmotic response is nonspecific and caused by concentration of intermediates involved in the ADH hydroosmotic response. However, researchers have shown that the onset (but not the maintenance) of the SH hydroosmotic response depends on an upregulation of adenylate cyclase (AC) activity, which can be pharmacologically modulated, indicating the involvement of a specific biological mechanism (48). The first aim of this study was to examine the role of AC in maintaining the SH hydroosmotic response in anuran bladder (Rana temporaria).

The serosal factor, or factors, involved in invoking the SH hydroosmotic response has yet to be elucidated. The response to SH is present but substantially lowered in sodium- and Ca2+-free and low-pH (6.6) serosal bathing medium (23). Similar "cationic" requirements are reported for the ADH-invoked hydroosmotic response (23). In contrast, no information exists on the effect of removal of the predominant medium anion, Cl–, on the SH hydroosmotic response. In light of this fact and the fact that activation of AC by halide ions (46), including Cl– (30), has been reported, the second aim of this study was to examine the importance of Cl– in the SH water response in anuran bladder.

In toad bladder, granular cell volume was initially reduced and thereafter returned to control values in the continued presence of hypertonic serosal perfusate (29). Cells, which have been osmotically shrunken, execute an acute response by a rapid uptake of NaCl (24). Na+/H+ exchangers (NHE) are known to be activated by cell shrinkage (5, 41). A third aim of this study was to investigate whether 5-n-ethyl-N-isopropyl amiloride (EIPA), a specific inhibitor of NHE, would have any effect on the functional response of anuran bladder to hypertonic serosal medium.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Male Rana temporaria, a frog indigenous to Ireland (supplied by Dennis McCarthy, Kells, County Meath, Ireland), were used in this study. Animals were killed by stunning, decerebration, and double pithing. Because bladders of R. temporaria are too small for catheterization, a modified version of Bentley's (3) gravimetric method for toad bladders was used. Bladders were always inflated with a hypotonic Ringer solution of tonicity dictated by the protocol [23 mosmol/kgH2O for the arginine vasopressin (AVP) protocol or 115 mosmol/kgH2O for the SH protocol; see below] by insertion of a fluid-filled syringe into the cloaca. The bladder was freed from its supporting mesenteric tissue, tied off with cotton thread, and dissected free to give a bilobed sac. This sac was immersed in a fixed volume (20 ml) of either isotonic (230 mosmol/kgH2O) or hypertonic (330 mosmol/kgH2O) Ringer solution, according to the protocol (see below). A hypertonic solution of 330 mosmol/kgH2O was used, as an increase of tonicity by 100 mosmol/kgH2O is within tolerated physiological values reported for the extracellular fluid of dehydrated anurans (54).

The test phase in all experiments was conducted with an osmotic gradient of ~200 mosmol/kgH2O across the tissue. Water movement was detected by a change in the weight of the sac. Bladders were weighed every 5 min; weight change in milligrams was converted to microliters, taking a density of 1.0 for fluid lost. Water flow is expressed as microliters per minute. Water bath temperature was maintained at 19°C (25).

Data Analysis

Results are expressed as means ± SE; n represents the number of independent experiments. Statistical analysis was carried out using unpaired Student's t-test with the exception of the data relating to Figs. 1B and GoGoGoGoGoGoGo9, A and B, where paired Student's t-test was employed as the bladders acted as their own controls. Differences were considered significant at P < 0.05.


Figure 1
View larger version (28K):
[in this window]
[in a new window]
  		Fig. 1. A: the hydroosmotic response to either arginine vasopressin (AVP; 20 mU/ml) in fresh isotonic bath, serosal hypertonicity (SH; NaCl), or SH (mannitol) in three separate bladder groups, where SH indicates serosal hypertonicity. Bladders were exposed to the hydroosmotic agent at time (t) = 40 min, after a control phase (t = 0–40 min) in isotonic bath. B: tissue responses upon exposure to the hydroosmotic agent in question for a second time (after a 30-min washout phase in isotonic bath) were of an equal magnitude to that seen during the first exposure (t = 40–70 min) to the agent in question. n, number of individual experiments. Arrows in graphs indicate bath change and/or addition of agent to the bath, as described in accompanying labels.

 

Figure 2
View larger version (11K):
[in this window]
[in a new window]
  		Fig. 2. SH-induced water movement is transepithelial. Bladders that exhibited a significant hydroosmotic response in hypertonic bath had no significant fluid loss when they were placed, after a control period in isotonic bath, in fresh hypertonic bath containing the water channel blocker HgCl2 (100 µM).

 

Figure 3
View larger version (12K):
[in this window]
[in a new window]
  		Fig. 3. Prostaglandins are not involved in invoking the hydroosmotic response. Control bladders ({square}) were incubated in isotonic Ringer alone for 120 min, with bath change at t = 60 min, before exposure to hypertonic bath. Test bladders ({triangleup}) were exposed to hypertonic bath containing indomethacin (10 µM) after 120 min incubation with the agent, in isotonic bath (with bath change at t = 60 min). Indomethacin did not inhibit but rather augmented the response. The response was reversed upon change to isotonic bath at t = 150, in the continued presence of indomethacin (10 µM).

 

Figure 4
View larger version (20K):
[in this window]
[in a new window]
  		Fig. 4. The hydroosmotic response to SH was reversed by norepinephrine (NE, 50 µM), be it in hypertonic-NaCl bath (A) or hypertonic-mannitol bath (B). NE was added to test bladder ({triangleup}) bath 15 min into a second exposure to either SH-NaCl (A) or SH-mannitol (B) at t = 115 min.

 

Figure 5
View larger version (14K):
[in this window]
[in a new window]
  		Fig. 5. There are two control groups: bladders exposed to SH (NaCl) alone ({square}) and bladders exposed to NE (50 µM) 15 min (t = 115 min) after exposure to SH ({triangleup}).The test group ({circ}) in each case examines the effect of blocking different categories of adrenergic receptors on the inhibitory effect of NE on the hydroosmotic response. The antagonist in each case (A-C) was added to isotonic bath at t = 85 min (upturned arrow) and was present in the fresh hypertonic bath (t = 100 min). A: prazosin (100 µM), a selective {alpha}1-antagonist, failed to block NE (50 µM) reversal of the hydroosmotic response in hypertonic bath. B: yohimbine (100 µM), a selective {alpha}2-antagonist, blocked NE (50 µM) reversal of the hydroosmotic response in hypertonic bath. C: propranolol (100 µM), a nonselective beta-antagonist, had no effect on the inhibitory action of NE (50 µM). D: NE (50 µM) reversed the SH hydroosmotic response, in the presence of indomethacin (10 µM). Test ({triangleup}) and control ({square}) bladders were preincubated for 120 min in isotonic Ringer + indomethacin (10 µM), with bath change at t = 60 min.

 

Figure 6
View larger version (16K):
[in this window]
[in a new window]
  		Fig. 6. A: the SH hydroosmotic response was abolished in Cl–-free bath. After a 40-min control phase in standard isotonic bath, test bladders ({triangleup}) were placed in hyperosmotic medium in which Cl– had been replaced by gluconate. B: bladders ({triangleup}) exhibited a reduced hydroosmotic response in hyperosmotic serosal medium in which there was 50% substitution of Cl– with gluconate. C: the SH water response was restored upon readdition of bath Cl–. After a 40-min control phase in standard isotonic medium, both bladder groups [test ({square}) and control (Figure 6)] were placed in Cl–-free hyperosmotic bath. At t = 70 min, control bladders placed in fresh Cl–-free hyperosmotic bath continued to exhibit low water permeability. By contrast, test bladders placed in standard hypertonic medium at t = 70 min showed a significant hydroosmotic response within 10 min at t = 80 min.

 

Figure 7
View larger version (14K):
[in this window]
[in a new window]
  		Fig. 7. A: the ADH-invoked water response was unaffected by removal of Cl– from the bathing medium. Test bladders ({triangleup}) were placed in Cl–-free isoosmotic bath containing AVP (20 mU/ml), after a control phase in standard isotonic bath. B: the response to AVP (20 mU/ml) was not augmented in hyperosmotic bath ({triangleup}) when Cl– was absent.

 

Figure 8
View larger version (5K):
[in this window]
[in a new window]
  		Fig. 8. The SH hydroosmotic response was inhibited in the presence of NPPB (50 µM), a Cl– channel blocker. Bumetanide (100 µM), an inhibitor of the Na/K/2Cl cotransporter, had no effect on tissue water permeability responses in hypertonic bath.

 

Figure 9
View larger version (9K):
[in this window]
[in a new window]
  		Fig. 9. A: SH-invoked water loss was inhibited by 5-n-ethyl-N-isopropyl amiloride (EIPA, 100 µM), an inhibitor of the Na+/H+ antiporter; bladders acted as their own controls. EIPA was present on a second exposure to SH, after a 30-min period in isotonic bath. B: The ADH-induced response was not augmented in hypertonic bath containing EIPA (100 µM). Again, bladders acted as their own controls. First exposure was to AVP (20 mU/ml) in hypertonic bath, followed by a washout period (30 min) in isotonic bath. Second exposure to AVP and SH combined was with EIPA (100 µM) in the bathing medium.

 
Solutions

Ringer solutions of varying tonicity were prepared in deionized water; pH was adjusted to 7.9 with HCl or NaOH to conform to reported values for anuran plasma pH (25).

Serosal (bath) solutions. Isotonic Ringer (230 ± 5 mosmol/kgH2O) contained (in mmol/l) 114.5 Na+, 119.0 Cl–, 3.7 K+, 1.0 Mg2+, 2.5 HCO3–, 0.9 Ca2+, 3.5 HEPES, 0.5 phosphate, and 5.0 glucose.

Hypertonic Ringer (330 ± 5 mosmol/kgH2O) was prepared by addition of either 50 mM NaCl-SH (NaCl) or 100 mM mannitol-SH (mannitol) to the isotonic Ringer recipe.

Cl–-free solutions were prepared by equimolar substitution of gluconate salts for Cl– salts, in the standard isotonic or hypertonic recipes. Adjustment of pH to 7.9 was with H2SO4 instead of HCl. As gluconate chelates Ca2+ (11), Ca2+ concentration was raised to 4.5 mol/l to compensate for reduction in activity of this ion. Control experiments using standard isotonic and hypertonic solutions containing 4.5 mmol/l Ca2+ confirmed that, at this concentration, there was no observable effect of the ion on either of the hydroosmotic responses.

Mucosal solutions. Solutions were prepared by reduction of NaCl concentration in the isotonic recipe to 6 mM (23 ± 3 mosmol/kgH2O) for AVP experiments or 56 mM (115 ± 5 mosmol/kgH2O) for SH experiments.

Chemicals

Because the sensitivity of anuran urinary bladder to ADH is altered by sequential increasing doses (16), classical dose-response curves are not possible. In separate bladder groups, responses were observed to 1, 2, 5, 10, 20, and 50 mU/ml AVP (unpublished observations). Maximal hydroosmotic responses to AVP were observed at 20 mU/ml.

HgCl2 was used at a final serosal bath concentration of 100 µM. Bumetanide, 5-nitro-2-(3-phenylpropylamino)benzoate (NPPB), and EIPA were used at bath concentrations of 100, 50, and 100 µM, respectively. Final serosal bath concentrations of other test agents were as follows: 50 µM norepinephrine (NE); 100 µM prazosin (a selective {alpha}1-antagonist); 100 µM yohimbine (a selective {alpha}2-antagonist); 100 µM propranolol (a nonselective beta-antagonist); and 10 µM indomethacin.

All chemicals were supplied by Sigma-Aldrich, Ireland, with the exception of NE (Winthrop Laboratories). Osmolality was measured on a model 3D3 Advanced Instruments Osmometer.

Protocols

AVP protocol (isotonic bath). Luminal fluid was 23 mosmol/kgH2O; bath fluid was 230 mosmol/kgH2O. At time (t) = 40 min, bladders were placed in fresh isotonic bath containing AVP (20 mU/ml); transmembrane osmotic gradient was {cong}200 mosmol/kgH2O. Washout was at t = 70 min, at which time bladders were placed in fresh isotonic bath.

SH protocol (hypertonic bath). Luminal fluid was 115 mosmol/kgH2O; bath fluid was 230 mosmol/kgH2O. At t = 40 min, bladders were placed in hypertonic bath (330 mosmol/kgH2O); transmembrane osmotic gradient was {cong}200 mosmol/kgH2O. Washout was at t = 70 min, at which time bladders were placed in fresh isotonic bath. Bladder exposure to SH and AVP combined was at t = 40 min; transmembrane osmotic gradient {cong}200 mosmol/kgH2O.

Repeated exposure to a hydroosmotic agent. In experiments where bladders were exposed to either AVP or SH for a second time, this was after a second control phase (t = 70–100 min) in fresh isotonic bath.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Hydroosmotic Response to SH and ADH

As seen in other anuran species, when R. temporaria bladder is exposed to either ADH or hypertonic bath (AVP and SH protocol respectively, cf. METHODS), the osmotic water permeability of the tissue increases, and water leaves the bladder along the transmural osmotic gradient, which is of the order of 200 mosmol/kgH2O in the test phase of both protocols (Fig. 1A). When this tissue is once again exposed to a hydroosmotic agent (Fig. 1B) be it AVP (20 mU/ml) or SH (330 mosmol/kgH2O), having been in fresh isotonic medium for 30 min, the osmotic permeability of the tissue again increases to a similar, if not slightly larger (but not statistically significant), degree. In separate bladder groups, first and second exposure exhibited mean fluid losses of 17.3 ± 2.8 and 20.2 ± 2.5 µl/min, 13.4 ± 2.7 and 15.8 ± 1.7 µl/min, 14.5 ± 2.7 and 15.4 ± 1.0 µl/min in isotonic bath + AVP, SH (NaCl), and SH (mannitol), respectively. In all three experimental groups, first and second exposure magnitudes were not statistically different (P > 0.05, paired t-test).

Determination of Whether Fluid Movement is Trans- or Paraepithelial

HgCl2 (100 µM) blocked fluid loss in hypertonic bathing medium (Fig. 2). Test bladders exhibited a hydroosmotic response with a mean flux of 20.4 ± 2.4 µl/min over the 30-min interval (t = 40–70 min) of the first exposure to SH. This value did not differ from that seen in control bladders (24.0 ± 5.9 µl/min) over the same time interval (P > 0.05, unpaired t-test). When the test bladders were again exposed to hypertonic medium, this time in the presence of HgCl2, the hydroosmotic response was significantly lower (2.1 ± 0.5 µl/min) than that seen in the control group (24.8 ± 4.8 µl/min; P < 0.01 unpaired t-test). HgCl2 did not disrupt the integrity of the epithelium, since analysis of test bladder fluid at the end of experiments showed that the transmural osmotic gradient was intact.

Investigation of a Role for Endogenous Prostaglandins in Invoking the SH Hydroosmotic Response

Test bladders were preincubated in isotonic medium containing indomethacin (10 µM) for 120 min (Fig. 3). The bathing medium was refreshed at t = 60 min to remove prostaglandins released by the bladder tissue into the bath (19, 62). Control bladders were preincubated in isotonic medium alone for 120 min. Weighings commenced at t = 90 min.

Mean fluid loss over the 30-min interval (t = 90–120 min) in isotonic bath was significantly higher in indomethacin-treated bladders than in the control group (11.9 ± 1.8 vs. 5.6 ± 1.8 µl/min; P < 0.04, unpaired t-test). Exposure to hypertonic bath for 30 min at t = 120–150 min (in the continued presence of indomethacin for the test group) showed similar large increases in osmotic water permeability: 39.3 ± 2.2 µl/min for the test group vs. 37.0 ± 2.9 µl/min for the control; P > 0.05, unpaired t-test. The SH response was reversed when bladders were placed in isotonic bath at t = 150 min (in the continued presence of indomethacin for the test group).

Determination of Effect of NE on the Developed Hydroosmotic Response in Hypertonic Bath

NE (50 µM) added to hypertonic (NaCl) bath at the peak of the hydroosmotic response (t = 115 min; 2nd exposure, after 30 min in isotonic bath) caused fluid loss to drop to basal levels: 7.9 ± 0.4 vs. 20.3 ± 4.0 µl/min in the control group over the time interval t = 120–140 min (P < 0.05, unpaired t-test; Fig. 4A).

A similar reversal (Fig. 4B) was seen when bladders undergoing a hyperosmotic response in hypertonic (mannitol) bath were exposed to NE (50 µM) at t = 115 min (2nd exposure, after 30 min in isotonic bath). Water permeability decreased in test bladders in comparison with control values over the time interval t = 120–140 min (5.7 ± 0.4 vs. 14.1 ± 1.2 µl/min, respectively, P < 0.005, unpaired t-test).

Because there is evidence of direct effects of mannitol on cell physiology (26, 31, 60) and because the increase of tonicity by addition of NaCl was more physiological, all subsequent investigations of the SH hydroosmotic response were with SH-NaCl bathing medium.

Determination of Receptor Type Involved in the Inhibitory Action of NE

Bladders (Fig. 5, A-C) exposed to SH alone or SH with addition of NE (50 µM) at the height of the hydroosmotic response to a second exposure to hypertonic bath (after a 30-min interval in fresh isotonic bath) functioned as control groups in a series of experiments to investigate the adrenergic receptor type involved in the NE reversal of the SH hydroosmotic response.

The selective {alpha}1-adrenergic receptor antagonist prazosin (100 µM) did not interfere with the reversal of the hydroosmotic response (Fig. 5A) by bath addition of NE (50 µM). Mean fluid loss over the 20-min interval (t = 120–140 min) after bladder exposure to NE was 5.7 ± 0.9 µl/min, which did not differ from the mean fluid loss (7.9 ± 0.4 µl/min) in bladders exposed to NE in its absence (P > 0.05; unpaired t-test; Fig. 5A).

In contrast, yohimbine (100 µM), which is a selective {alpha}2-adrenergic receptor antagonist, inhibited the reversal of the developed SH hydroosmotic response by NE (50 µM; Fig. 5B). Mean fluid loss over the 20-min interval after bath addition of NE at t = 115 min was 15.4 ± 2.6 µl/min, which did not significantly differ from the magnitude of the fluid loss (17.4 ± 1.7 µl/min) in the control group exposed to SH alone (P > 0.05, unpaired t-test).

Propranolol (100 µM), which blocks beta-adrenergic receptors in a nonselective manner, had no effect on the reversal by NE (50 µM) of the hydroosmotic response (Fig. 5C). Mean fluid loss was equally decreased in the presence (10.3 ± 1.3 µl/min) and absence (7.9 ± 0.41.3 µl/min) of the beta-blocker (P > 0.05, unpaired t-test).

Determination of Whether the Inhibitory Effect of NE via {alpha}2-Adrenergic Receptor Activation was Mediated Indirectly by Endogenous Prostaglandins

It was necessary to assess a possible role for prostaglandins in the inhibitory effect of NE on the developed SH hydroosmotic response. Bladders preincubated (120 min) with indomethacin (10 µM) exhibited a significant reversal of the hydroosmotic response when exposed to NE (50 µM) at the height of the response in hypertonic bath, in the continued presence of indomethacin (Fig. 5D). Mean fluid loss decreased to 6.1 ± 0.2 µl/min, which differed significantly from the mean value of 21.5 ± 2.1 µl/min recorded in control bladders (Fig. 5D) exposed to SH alone, in the continued presence of indomethacin, over the same time interval (P < 0.003, unpaired t-test). These findings contraindicate a role for prostaglandins and point to a direct effect of NE on the developed response by inhibition of AC activity.

Determination of the Anionic Requirements of SH Hydroosmotic Response

Bladders placed in "Cl–-free" hyperosmotic bath (Fig. 6A), in which medium Cl– had been substituted with the nonpermeant anion gluconate, showed a significantly different response to hypertonicity when compared with control bladders exposed to standard hypertonic bath; mean fluid loss over the 30-min exposure to SH was 3.6 ± 0.9 and 16.1 ± 1.8 µl/min, respectively (P < 0.005, unpaired t-test).

Analysis of luminal fluid at term of experiments in hyperosmotic Cl–-free gluconate bath (Fig. 6A) showed that Na+, K+, and Cl– concentrations and osmolality had not significantly changed from their corresponding values in the hypotonic fluid used to fill the bladders at the start of the experiments. Thus gluconate had not compromised junctional integrity, in agreement with earlier observations (21, 35, 57).

In a further set of experiments (Fig. 6B), bladders were exposed to hyperosmotic bath in which there had been a 50% replacement of Cl– with gluconate; mean fluid loss was 12.5 ± 2.5 µl/min. This response was significantly lower than the hydroosmotic control bladders in standard hypertonic bath (23.3 ± 2.0 µl/min; P < 0.01, unpaired t-test) but significantly larger than the response of bladders in Cl–-free bath (5.0 ± 0.7 µl/min; P < 0.005, unpaired t-test) over the 30-min exposure of the three groups to hypertonicity.

Determination of Whether the Abolition of the SH Hydroosmotic Response by Complete Cl– Removal Can be Reversed by Readdition of Cl– to the Bathing Medium

After a control period (t = 0–40 min) in standard isotonic bath, bladders were placed in Cl–-free hyperosmotic bath for 30 min (Fig. 6C). At t = 70 min, three bladders (test) were placed in standard hypertonic bath, while the remaining three (control) were placed in fresh Cl–-free hyperosmotic medium. With Cl– present in the bathing medium, test bladders had a substantial fluid loss within 10 min (t = 80 min) compared with the continued poor response seen in the control bladders (12.7 ± 2.5 vs. 4.7 ± 1.1 µl/min, respectively, P < 0.04, unpaired t-test).

Replacement of Cl– in serosal bath by the nonpermeant anion gluconate causes cell loss of Cl–, accompanied by potassium to maintain electroneutrality (35). The possibility that an indirect mechanism involving intracellular K+ concentration might be responsible for the abolition of the SH response in Cl–-free bath was contraindicated in experiments carried out to measure the hydroosmotic response of bladders exposed to "K+-free" hypertonic bath. Test bladders (n = 5) exposed to K+-free hypertonic bath at t = 40 min had a mean fluid loss of 17.9 ± 4.0 µl/min over 30 min, which was not significantly different (P > 0.05, unpaired t-test) from the hydroosmotic response (19.0 ± 3.0 µl/min) in the control group (n = 5) exposed to standard hypertonic bath over the same time interval (data only).

Determination of Cl– Requirement by the ADH Hydroosmotic Response

The hormone-invoked hydroosmotic response was not affected by the absence of bath Cl–. In isoosmotic conditions (Fig. 7A), the magnitude of the response to a maximal dose of AVP (20 mU/ml) in the test bladders was similar to that seen in the control group. Over the 30-min exposure to AVP, mean fluid loss was 15.4 ± 1.9 and 16.3 ± 1.3 µl/min, respectively (P > 0.05, unpaired t-test).

In Cl–-free hyperosmotic bath (Fig. 7B), the hydroosmotic response to AVP (20 mU/ml) was substantial. However, the augmentation of the response as seen in standard hypertonic bath was absent. Mean fluid loss was 25.3 ± 2.2 and 40.1 ± 2.5 µl/min, respectively (P < 0.005, unpaired t-test).

Examination of a Possible Role for a Cl– Transporter or Channel in the SH Response

Bumetanide (100 µM), which inhibits the Na/K/2Cl cotransporter, did not affect the hydroosmotic response to SH (Fig. 8). Mean fluid loss over the 30 min in hypertonic bath with bumetanide was 20.1 ± 3.9 µl/min compared with 23.9 ± 5.8 µl/min in control bladders exposed to SH alone (P > 0.05, unpaired t-test). By comparison, NPPB (50 µM), a Cl–-channel blocker, significantly reduced the hydroosmotic response compared with the control group (Fig. 8); mean fluid loss was 3.6 ± 0.9 µl/min (P < 0.01, unpaired t-test).

Effect of Inhibition of NHE on the SH Response

After a 30-min control period (t = 70–100 min) in isotonic bath, bladders were exposed for a second time to either SH (Fig. 9A) or SH + AVP (Fig. 9B), but now with EIPA (100 µM) in the bathing medium; these bladder groups therefore acted as their own controls. EIPA, which blocks the NHE, had an inhibitory effect on the response to SH alone (Fig. 9A); mean fluid loss was 3.2 ± 1.7 µl/min compared with a loss of 8.0 ± 2.1 µl/min seen upon a first exposure to SH, over a similar time interval (P < 0.005, paired t-test). The response to AVP (20 mU/ml) was no longer augmented in hypertonic bath when EIPA was present in the bathing medium (Fig. 9B). Mean fluid loss was 12.8 ± 1.0 µl/min compared with a mean loss of 29.7 ± 2.9 µl/min observed during the first exposure to SH (P < 0.005, paired t-test).


   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
In agreement with earlier reports (4, 48), we show that anuran urinary bladder undergoes an increase in membrane water permeability when exposed to either ADH (AVP) or hypertonic bath (Fig. 1A). This response was reversed when bladders were placed in fresh isotonic bath and reoccurred with an equal magnitude when bladders were reexposed 30 min later to the hydroosmotic agent, be it AVP or SH (Fig. 1B).

There is evidence for permanent water channels in the basolateral membrane of frog bladder epithelial cells; these channels are blocked by the presence of mercurials (HgCl2 and P-chloromercuribenzene sulfonate) in the serosal bathing solution (58). Our functional studies with HgCl2 (Fig. 2) would support a transcellular route for water movement across the epithelium. Luminal fluid from the test group was still hypotonic at the end of the experiments, indicating that the junctional integrity had not been disrupted by the mercurial.

In contrast to a known inhibitory effect of prostaglandins on the ADH and SH hydroosmotic response in anuran bladder (40, 48), frog bladders exposed to low concentrations of PGE2 in isotonic medium are reported to undergo an increase in osmotic water permeability, without ADH (42). It was necessary to investigate whether a low endogenous prostaglandin synthesis, resulting from exposure of bladders to hypertonic bath (12), might be involved in invoking the hydroosmotic response.

Preincubation of toad urinary bladder in isotonic bath with indomethacin (10 µM) for 120 min is reported to inhibit PGE2 synthesis in toad urinary bladder (19). In test bladders (Fig. 3), the SH hydroosmotic response was not abolished by the depletion of bath prostaglandin but, rather, the magnitude of fluid loss was larger than that seen in experiments carried out under the standard SH protocol. Indomethacin significantly increased basal fluid loss (t = 90–120 min) in test bladders compared with control values (Fig. 3), in agreement with the finding of other researchers (1). Indomethacin is reported to inhibit phosphodiesterase activity (17); however, such an action is contraindicated by the fact that osmotic water permeability was decreased rapidly when the test group was placed in fresh isotonic bath at t = 150 min in the continued presence of indomethacin.

In anuran urinary bladder, NE is reported to inhibit the onset and maintenance of the ADH hydroosmotic response and, in addition, the onset of the hydroosmotic response to SH (48). We had similar findings (data not shown).

We show for the first time that the SH hydroosmotic response is reversed by NE, be it in SH-NaCl bath (Fig. 4A) or SH-mannitol bath (Fig. 4B). This reversal is inhibited by yohimbine (Fig. 5A) but not by prazosin (Fig. 5B) or propranolol (Fig. 5C), indicating that NE is acting via {alpha}2-adrenergic receptors. The {alpha}2-adrenergic receptor is a G protein-linked receptor known to inhibit AC (45). This reversal is also seen in tissue preexposed to indomethacin for 120 min (Fig. 5D), contraindicating an indirect role for prostaglandins (49) in the reversal by NE of the SH hydroosmotic response.

Using a volumetric method (7), Ripoche and coworkers (48) failed to demonstrate a reversal by NE of the hydroosmotic response in SH-mannitol (450 mosmol/kgH2O), whereas their results for NE addition postexposure of bladders to SH-NaCl (450 mosmol/kgH2O) were inconclusive. The authors concluded that, once initiated, the SH hydroosmotic response differed from that invoked by ADH; the latter depended on cAMP for its maintenance, whereas the former did not.

The failure of NE to reverse the hydroosmotic response in SH-mannitol, as noted by this group of researchers, may have been because of the high concentration (220 mM) of mannitol, in combination with the final tonicity (450 mosmol/kgH2O) of the bathing medium, used in the study (48). Under these conditions, mannitol may have interfered with the action of NE either directly at the level of receptor binding by the agonist or indirectly via intracellular events (31, 60).

In our hands, using the gravimetric method and a serosal hypertonic bathing solution (330 mosmol/kgH2O) within a physiological range, known to be tolerated in vivo (54), both types of SH hydroosmotic response were reversed by NE; this reversal is shown to be mediated by {alpha}2-adrenergic receptors and not to involve prostaglandins. Our findings indicate that the hydroosmotic response of anuran bladder to SH is similar in both onset and maintenance to that invoked by ADH; both stages depend on AC activity.

In the dehydrated anuran, the ability to selectively block hydroosmotic responses of the urinary bladder via neural pathways would be advantageous. When an external water source is available, rehydration would be by dermal "drinking," and the reserve water in the bladder would not be compromised. There is evidence of dermal drinking with water present in the bladder (27). It has been shown that both NE and the specific beta-agonist, isoprenaline, stimulate water flow across toad pelvic patch skin but fail to do so in the bladders of the same animal (13).

When Cl– is absent from the bathing medium (Fig. 6A), the SH response is abolished; by contrast, the ADH hydroosmotic response is unaffected under these conditions (Fig. 7, A and B). The hydroosmotic response to a maximal dose of AVP (20 mU/ml) is augmented in hypertonic bath (Fig. 7B). The finding that this augmentation does not occur in Cl–-free hyperosmotic bath (Fig. 7B) is consistent with a specific additive role of SH, resulting from an independent stimulation of water flow. It is intriguing to consider the possibility that two different isoforms of AC are involved in mediating the hormone-dependent (ADH) and the hormone-independent (SH) hydroosmotic responses in anuran urinary bladder. The existence of more than one isoform of AC in this tissue has already been suggested (53) based on the observation that the ADH-invoked natriferic and hydroosmotic responses can be differentially inhibited (36, 44). The two predominant cell types in anuran bladder are the mitochondria-rich (MR) cell and the granular cell (43). A role for MR cells (via intercellular movement of cAMP) in the response of granular cells to ADH has been proposed (20, 52). It is also possible that the AC activated in the SH hydroosmotic response is in a separate cytoplasmic compartment and that the response involves a separately regulated pool of water channels.

The causative agent or agents in the SH hydroosmotic response remain unknown. Our findings indicate an important role for Cl– in the SH hydroosmotic response. This may be a factor of the actual concentration of the anion at the serosal face of the tissue, since bladders exhibited a diminished hydroosmotic response when bath Cl– was reduced by 50% (Fig. 6B), whereas the response was abolished in Cl–-free hyperosmotic medium (Fig. 6B). Intracellular Cl– concentration may also be an important factor, since the SH response is restored within 10 min of exposure to standard hypertonic bath (t = 70 min; Fig. 6C). This suggests a need to increase intracellular Cl– concentration from its depleted levels,1 resulting in a normal distribution of Cl– across the membrane.

Examination of the effects of NPPB and bumetanide (Fig. 8) represents a preliminary investigation of the mechanisms of the Cl– dependence of the hydroosmotic response. The response is sensitive to serosal NPPB but not to serosal bumetanide, suggesting a role for a Cl– channel rather than a transporter in the response.

EIPA (100 µM), a specific inhibitor of NHE, caused a significant decrease in the hydroosmotic response (Fig. 9A) and significantly reduced the augmentation of the AVP response in hypertonic bath (Fig. 9B). These results are very similar to those seen in the absence of bath Cl– (Figs. 6A and 7B), raising the possibility that there may be a functional link between these two parameters, namely Cl– concentration and Na+/H+ activity, in the hydroosmotic response in this tissue.

The possibility that bath absence of Cl– and also inhibition of NHE might cause intracellular pH (pHi) to fall is contraindicated by the fact that, under both of these experimental conditions, the AVP response, which is known to be inhibited by intracellular acidification (8), is present (Figs. 7, A and B, and 9B). NHE activation in shrinkage situations has been attributed to a shift in the flux vs. pHi profile of the exchanger in an alkaline direction (5), resulting in an increase in pHi. In R. temporaria urinary bladder, an intracellular alkalization in hypertonic bath, resulting from activity of Na+/H+, might have a permissive effect on the activation of AC by another factor, such as the Cl– anion. Activation of AC by halide ions (46), including Cl– (30, 34, 56) has been reported.

In the mammalian collecting duct, ADH activation of V2 receptors is in the presence of a hypertonic extracellular fluid. Reports of a hormone-independent effect of hypertonicity in the mammalian system are scant. However, those that do exist indicate a potential independent input by hypertonicity on water and urea permeability (32, 50).

The results presented here add to the increasing evidence that the hormone-independent hydroosmotic response of anuran bladder in hypertonic bath involves specific biochemical steps and is not simply a concentration artifact resulting from cell shrinkage.


   GRANTS
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by a research grant from the Health Research Board of Ireland.


   ACKNOWLEDGMENTS
 
Present address of A. T. Hanna-Mitchell: Renal-Electrolyte Div., Dept. of Medicine, Univ. of Pittsburgh, A1209 Scaife Hall, 3550 Terrace St., Pittsburgh, PA 15261 (e-mail: ahannam@pitt.edu).


   FOOTNOTES
 

Address for reprint requests and other correspondence: E. M. Gebruers, Dept. of Physiology, Aras Windle, Univ. College Cork, Cork, Ireland (e-mail: e.gebruers{at}ucc.i.e)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Incubation (120 min) of toad bladder cells in Cl–-free isoosmotic gluconate Ringer solution caused intracellular Cl– concentration to fall to essentially zero (35). Back


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Alvo M, Espinoza AM, Fernandez V, and Marusic ET. Alpha 2-agonists block ADH action in toad bladder and this inhibition is not modified by indomethacin. Am J Physiol Renal Fluid Electrolyte Physiol 255: F74–F77, 1988.[Abstract/Free Full Text]
  2. Bakker HR and Bradshaw SD. Effect of hypothalamic lesions on water metabolism of the toad Bufo marinus. J Endocrinol 75: 161–172, 1977.[Abstract/Free Full Text]
  3. Bentley PJ. The effects of neurohypophyseal extracts on water transfer across the wall of the isolated urinary bladder of the toad Bufo marinus. J Endocrinol 17: 201–209, 1958.[Abstract/Free Full Text]
  4. Bentley PJ. Physiological properties of the isolated frog bladder in hyper-osmotic solutions. Comp Biochem Physiol 12: 233–239, 1964.[Medline]
  5. Bevensee MO, Bashi E, Wolf-Rüdiger S, Boyarsky G, and Boron WF. Shrinkage-induced activation of Na+/H+ exchange in rat renal mesangial cells. Am J Physiol Cell Physiol 276: C674–C683, 1999.[Abstract/Free Full Text]
  6. Bourguet J and Jard S. Un dispositif automatique de mesure et d'enregistrement du flux net d'eau à travers la peau et la vessie des amphibians. Biochim Biophys Acta 88: 442–444, 1964.[Medline]
  7. Bourguet J, Chevalier J, and Hugon JS. Alterations in membrane-associated particle distribution during anti-diuretic challenge in frog urinary bladder epithelium. Biophys J 16: 627–639, 1976.[Web of Science][Medline]
  8. Brem AS, Eich E, Pearl M, and Taylor A. Anion transport inhibitors: effects on water and sodium transport in the toad urinary bladder. Am J Physiol Renal Fluid Electrolyte Physiol 248: F594–F601, 1985.[Abstract/Free Full Text]
  9. Brunn F. Beitrag zur kenntnis der wirkung von hypophysenextraken auf den wasserhaushalt des frosches. Z Gesammte Experimentelle Medizin 25: 120–125, 1921.
  10. Chevalier J, Bourguet J, and Hugon JS. Membrane associated particles: distribution in frog urinary bladder epithelium at rest and after oxytocin treatment. Cell Tissue Res 152: 129–140, 1974.[Web of Science][Medline]
  11. Christoffersen CR and Skibsted LH. Calcium ion activity in physiological salt solutions: influence of anions substituted for chloride. Comp Biochem Physiol A 52: 317–322, 1975.[Medline]
  12. Danon A, Knapp HR, Oelz O, and Oates JA. Stimulation of prostaglandin biosynthesis in the renal papilla by hypertonic mediums. Am J Physiol Renal Fluid Electrolyte Physiol 234: F64–F67, 1978.[Free Full Text]
  13. De Sousa RC and Grosso A. Osmotic water flow across the abdominal skin of the toad Bufo marinus: effect of vasopressin and isoprenaline. J Physiol 329: 281–296, 1982.[Abstract/Free Full Text]
  14. Dratwa M and Tisher C. Effect of hypertonicity and colchicine on the intramembranous particle aggregation in toad urinary bladder. Cell Tissue Res 196: 263–269, 1979.[Web of Science][Medline]
  15. Edwards RM, Jackson BA, and Dousa TP. ADH-sensitive cAMP system in papillary collecting duct: Effect of osmolality and PGE2. Am J Physiol Renal Fluid Electrolyte Physiol 240: F311–F318, 1981.[Abstract/Free Full Text]
  16. Eggena P. An osmometric method for the bioassay of vasotocin and related peptides in the toad bladder. Endocrinology 115: 2104–2112, 1984.[Abstract/Free Full Text]
  17. Flores AG and Sharp GW. Endogenous prostaglandins and osmotic water flow in the toad bladder. Am J Physiol 233: 1392–1397, 1972.
  18. Forrest JN Jr and Goodman DB. pH-dependent prostaglandin E2 production and somatostatin modulators of the action of vasopressin in the toad urinary bladder. Ann NY Acad Sci 372: 180–193, 1981.[Medline]
  19. Forrest JN Jr, Schneider CJ, and Goodman DB. Role of prostaglandin E2 in mediating the effects of pH on the hydroosmotic response to vasopressin in the toad urinary bladder. J Clin Invest 69: 499–506, 1982.[Web of Science][Medline]
  20. Goodman DB, Bloom FE, Battenberg ER, Rasmussen H, and Davis WL. Immunofluorescent localization of cyclic AMP in toad urinary bladder, possible intercellular transfer. Science 188: 1023–1025, 1975.[Abstract/Free Full Text]
  21. Gordon LG. Electrical transients produced by the toad urinary bladder in response to altered medium osmolality. J Physiol 406: 371–392, 1988.[Abstract/Free Full Text]
  22. Handler JS, Butcher RW, Sutherland EW, and Orloff J. The effect of vasopressin and of theophylline on the concentration of adenosine 3', 5'-phosphate in the urinary bladder of the toad. J Biol Chem 240: 4524–4526, 1965.[Free Full Text]
  23. Hardy MA. Ionic requirements of the transepithelial water flow induced by hypertonicity. In: Les Colloques de L'INSERM (Contrôle Hormonal Des Transporte Epitheliaux). Paris: INSERM, 1979, vol. 85, p. 311–322.
  24. Hoffman EK and Simonsen LO. Membrane mechanisms in volume and pH regulation in vertebrate cells. Physiol Rev 69: 315–382, 1989.[Free Full Text]
  25. Howall BJ, Baumgardner FW, Bondi K, and Rahn H. Acid-base balance in cold-blooded vertebrates as a function of body temperature. Am J Physiol 218: 600–606, 1970.[Free Full Text]
  26. Johnston PA, Bernard DB, Perrin NS, and Levinsky NG. Prostaglandins mediate the vasodilatory effect of mannitol in the hyperperfused rat kidney. J Clin Invest 68: 127–133, 1981.[Web of Science][Medline]
  27. Jørgensen CB. Water economy in a terrestrial toad (Bufo bufo), with special reference to cutaneous drinking and urinary bladder function. Comp Biochem Physiol A 109: 311–324, 1994.[CrossRef]
  28. Jørgensen CB. 200 years of amphibian water economy: from Robert Townson to the present. Biol Rev Camb Philos Soc 72: 153–237, 1997.[Medline]
  29. Kachadorian WA, Spring KR, Shinowara NL, Muller J, Palaia TA, and Discala VA. Effects of serosal hypertonicity on water permeability in toad urinary bladder. Am J Physiol Cell Physiol 258: C871–C878, 1990.[Abstract/Free Full Text]
  30. Kalish MI, Pineyro MA, Cooper B, and Gregerman RI. Adenylyl cyclase activation by halide anions other than fluoride. Biochem Biophys Res Commun 61: 781–787, 1974.[CrossRef][Web of Science][Medline]
  31. Krishnamurty VS, Adams HR, and Willerson JT. Paradoxical inhibition of vasoconstrictor and vasodilator responses by hypertonic mannitol in isolated arterial smooth muscle. Eur J Pharmacol 58: 379–388, 1979.[CrossRef][Web of Science][Medline]
  32. Kudo LH, César KR, Ping WC, and Rocha AS. Effect of peritubular hypertonicity on water and urea transport of inner medullary collecting duct. Am J Physiol Renal Physiol 262: F338–F347, 1992.[Abstract/Free Full Text]
  33. Kurokawa K and Massry SG. Interaction between catecholamines and vasopressin on renal medullary cyclic AMP of rat. Am J Physiol 225: 825–829, 1973.[Free Full Text]
  34. Leclerc L, Harding SE, and Harris P. The effect of anions and cations on cardiac adenylate cyclase: interactions with isoprenaline and GTP. Biochem Biophys Res Commun 118: 561–566, 1984.[CrossRef][Web of Science][Medline]
  35. Lewis SA, Butt AG, Bowler MJ, Leader JP, and Macknight AD. Effects of anions on cellular volume and transepithelial Na+ transport across toad urinary bladder. J Membr Biol 83: 119–137, 1985.[CrossRef][Web of Science][Medline]
  36. Lipson LC and Sharp GW. Effect of prostaglandin E1 on sodium transport and osmotic water flow in the toad bladder. Am J Physiol 220: 1046–1052, 1971.[Free Full Text]
  37. Masur SK, Holtzman E, and Walter R. Hormone-stimulated exocytosis in the toad urinary bladder. Some possible implications for turnover of surface membranes. J Cell Biol 52: 211–219, 1972.[Free Full Text]
  38. McClanahan LL, Ruibal R, and Shoemaker VH. Frogs and toads in deserts. Sci Am 270: 82–88, 1994.[Web of Science][Medline]
  39. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, and Knepper MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 92: 1013–1017, 1995.[Abstract/Free Full Text]
  40. Orloff J, Handler JS, and Bergstrom S. Effects of prostaglandin (PGE-1) on the permeability response of toad bladder to vasopressin, theophylline and adenosine 3', 5'-monophosphate. Nature 205: 397–398, 1965.[CrossRef][Medline]
  41. Parker JC and Castranova V. Volume-responsive sodium and proton movements in dog red blood cells. J Gen Physiol 84: 379–401, 1984.[Abstract/Free Full Text]
  42. Parnova RG, Schakhmatova EI, Plesneva SA, Getmanova EV, Korolev EV, Komissarchik YY, and Natochin Y. Role of prostaglandin E2 in regulation of low and high water osmotic permeability in frog urinary bladder. Biochim Biophys Acta 1356: 160–170, 1997.[Medline]
  43. Peachy LD and Rasmussen H. Structure of the toad's urinary bladder as related to its physiology. J Biophys Biochem Cytol 10: 529–553, 1961.
  44. Petersen MJ and Edelman IS. Calcium inhibition of the action of vasopressin on the urinary bladder of the toad. J Clin Invest 43: 583–594, 1964.[Web of Science][Medline]
  45. Pettinger WA, Umemura S, Smyth DD, and Jeffries WB. Renal alpha 2-adrenoceptors and the adenylate cyclase-cAMP system: biochemical and physiological interactions. Am J Physiol Renal Fluid Electrolyte Physiol 252: F199–F205, 1987.[Abstract/Free Full Text]
  46. Rall TW and Sutherland EW. Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem 232: 1065–1076, 1958.[Free Full Text]
  47. Ripoche P, Parisi M, and Bourguet J. Mechanism of the "antidiuretic hormone-like" action of hypertonic media on the frog urinary bladder. Biochim Biophys Acta 193: 231–234, 1969.[Medline]
  48. Ripoche P, Bourguet J, and Parisi M. The effect of hypertonic media on water permeability of frog urinary bladder. Inhibition by catecholamines and prostaglandin E 1. J Gen Physiol 61: 110–124, 1973.[Abstract/Free Full Text]
  49. Rouch AJ and Kudo LH. Role of PGE2 in {alpha}2-induced inhibition of AVP- and cAMP-stimulated H2O, Na+, and urea transport in rat IMCD. Am J Physiol Renal Physiol 279: F294–F301, 2000.[Abstract/Free Full Text]
  50. Sands JM. Regulation of renal urea transporters. J Am Soc Nephrol 10: 635–646, 1999.[Abstract/Free Full Text]
  51. Sawyer WH and Schisgall RM. Increased permeability of the frog bladder to water in response to dehydration and neurohypophysial extracts. Am J Physiol 187: 312–314, 1956.[Abstract/Free Full Text]
  52. Scott WN, Sapirstein VS, and Yoder MJ. Partition of tissue functions in epithelia: localization of enzymes in "mitochondria-rich" cells of toad urinary bladder. Science 184: 797–800, 1974.[Abstract/Free Full Text]
  53. Sharp GW. Water flow studies in toad bladder and the effect of antidiuretic hormones. Methods Enzymol 37: 251–256, 1975.
  54. Shoemaker VH. The effects of dehydration on electrolyte concentration in a toad, Bufo marinus. Comp Biochem Physiol 13: 261–271, 1964.[Medline]
  55. Shoemaker VH and Waring H. Effect of hypothalamic lesions on the water balance response of a toad (Bufo marinus). Comp Biochem Physiol 24: 47–54, 1968.[Medline]
  56. Toyoshige M, Basi NS, and Rebois RV. Chloride effects on Gs subunit dissociation. Fluoroaluminate binding to Gs does not cause subunit dissociation in the absence of chloride ion. J Biol Chem 271: 8791–8795, 1996.[Abstract/Free Full Text]
  57. Ussing HH. Relationship between osmotic reactions and active sodium transport in the frog skin epithelium. Acta Physiol Scand 63: 141–155, 1965.[Web of Science][Medline]
  58. Van Der Goot F, Corman B, and Ripoche P. Evidence for permanent water channels in the basolateral membrane of an ADH-sensitive epithelium. J Membr Biol 120: 59–65, 1991.[CrossRef][Web of Science][Medline]
  59. Wade JB, Stetson DL, and Lewis SA. ADH action: evidence for a membrane shuttle mechanism. Ann NY Acad Sci 372: 106–117, 1981.[Medline]
  60. Whikehart DR, Angelos P, and Montgomery B. Effects of mannitol on cultured corneal endothelial cell Na, K-ATPase activity. Cornea 14: 295–299, 1995.[CrossRef][Web of Science][Medline]
  61. Wingstrand KG, Jørgensen CB, and Rosenkilde P. Role of the preoptic-neurohypophyseal system in the water economy of the toad Bufo bufo L. Gen Comp Endocrinol 12: 91–98, 1969.[CrossRef][Web of Science][Medline]
  62. Zusman RM, Keiser HR, and Handler JS. Vasopressin-stimulated prostaglandin E biosynthesis in the toad urinary bladder. Effect on water flow. J Clin Invest 60: 1339–1347, 1977.[Web of Science][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/1/R213    most recent
00652.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanna-Mitchell, A. T.
Right arrow Articles by Gebruers, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanna-Mitchell, A. T.
Right arrow Articles by Gebruers, E. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.